Physician profile
Bryan M Honaker
NPI 1356328066
$7,621.28
in general payments reported to CMS, 2019-2025
42 companies · $923 in 2025
The $923 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,186 · 2020: $789 · 2021: $1,238 · 2022: $1,065 · 2023: $1,221 · 2024: $1,200 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,344.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $939.75 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $777.92 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $747.97 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $719.59 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $485.52 | 2019-2025 | |
| Amarin Pharma, INC. | $477.47 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $417.52 | 2019-2025 | Jardiance |
| Abbvie INC. | $268.94 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $207.91 | 2020-2024 | |
| Phathom Pharmaceuticals, INC. | $206.27 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $182.96 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $168.63 | 2023-2025 | Repatha, Otezla, Repatha |
| Sumitomo Pharma America, INC. | $160.46 | 2023-2025 | Gemtesa |
| Sunovion Pharmaceuticals INC. | $157.93 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $152.07 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Honaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.